Total Funding
63
55
Total FundingVenture - Series Unknown raised
Growth Score 63 in past quarter
-12 pts
Heat Score 55 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
48355
Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.
Nagesh K. Mahanthappa: Non Executive DirectorPast Role: Exo Therapeutics, Independent Director- Derek Stemple: CTO and Co-Founder
About the Company
Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existing
Phosphoramidite synthesis technology.
Camena Bioscience was founded in 2016 and is headquartered in Cambridge.